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An elderly woman was seen for evaluation of a
pruritic rash on her trunk and proximal extremities.
Clinically and histologically the lesions resembled
mycosis fungoides (MF). Two additional lesions on
her back, with differing morphology, were proven to
be cutaneous B-cell lymphoma on pathology and
gene rearrangement. Several case reports have
shown that MF is a risk factor for the development
of a secondary B-cell lymphoma. However, it is
extremely rare for the two discordant lymphomas to
present simultaneously in the same patient.
CASE REPORT
An 81-year-old immunocompetent woman pre-
sented to the dermatology department on referral
from her primary care physician for treatment of a
pruritic rash. The rash had been present on her trunk
for approximately 18 months, and to the knowledge
of the patient, the lesions all presented at the same
time. She otherwise felt well with no complaints of
fevers, chills, night sweats, or weight loss. Upon
examination, the patient was found to have multiple
pink, scaly patches and plaques clinically suggestive
of MF on the trunk and bilateral axillae (Fig 1) in
addition to 2 erythematous, indurated plaques on
the mid back (Fig 2). There was no palpable
lymphadenopathy or hepatosplenomegaly.
A biopsy of the plaque at the right portion of the
upper chest, stained with hematoxylin-eosin, found
enlarged lymphocytes with hyperchromatic irregular
nuclei. Epidermotropism and focal Pautrier
microabscesses were present. The papillary dermis
was hyalinized. The lymphocytes were highlighted
on CD3 staining, and most cells expressed CD4 with
little CD8 expression. No significant CD20 staining
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ings were consistent with MF.
Biopsies of the right and left mid back found a
dense, diffuse infiltrate of predominantly lympho-
cytes with histiocytes and occasional plasma cells.
The lymphocytes were not significantly enlarged and
had angulated to round nuclei and inconspicuous
nucleoli. CD20 and CD79a highlighted most of the
lymphocytes and a smaller population of CD31
lymphocytes was seen at the base of the lesion.
Kappa and Lambda staining highlighted plasma
cells, but no significant clonal shift was identified.
B- and T-cell gene rearrangement was performed,
and a B-cell (IgH) clone was identified. Additional
immunostaining was performed and the morpho-
logic features, together with the immunophenotype
(CD201, CD79a1, bcl61, bcl21partial, CD10) and
identification of a B-cell clone, was most suggestive
of a low-grade B-cell lymphoma (Figs 3 and 4). In
situ hybridization stain for Epstein Barr virus was also
performed, and results were negative.
On referral to the oncology department, labora-
tory results showed awhite blood cell count of 6,760,
hemoglobin of 12.5, platelet count of 127,000, and
basophilia with a basophil count of 3.8%. Sezary
cell count showed 5% lymphocytes with features
consistent with Sezary cells. Computed tomography
scan of the chest found a 3.3-cm enlarged node in the
preaortic space, small bilateral axillary adenopathy,
and small bilateral pulmonary nodules worrisome
for metastatic disease. Bone marrow biopsy found
increased numbers of T cells both in small lymphoid2352-5126
 2015 by the American Academy of Dermatology, Inc. Published
by Elsevier, Inc. This is an open access article under the CC
BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).
http://dx.doi.org/10.1016/j.jdcr.2015.04.015
219
Fig 3. Biopsy specimen of chest shows CD3 positivity of
lymphocytic infiltrate with moderate cytologic atypia,
hyperchromatism, and scattered mitotic figures consistent
with MF. (Hematoxylin-eosin stain.)
Fig 4. Biopsy specimen of back shows CD20 positivity
of a dense, lymphoid infiltrate consistent with B-cell
lymphoma. (Hematoxylin-eosin stain.)
Fig 1. Erythematous scaling plaque clinically suggestive
of MF on the right upper portion of the chest.
Fig 2. Erythematous, indurated plaques on the midback
demonstrating B-cell lymphoma.
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marrow. Flow cytometry found gating on 19% of
cells, 87% CD3, 73% CD4/CD3, and 10% CD8/CD3.
Left axillary lymph node histology found small
to medium lymphoid cells with some nuclear
irregularity and inconspicuous nucleoli. The cells
showed lack of expression of CD30 on immuno-
histochemical staining. Cytometry found an
abundance of T lymphocytes, of which most
expressed CD4 and were negative for CD8. The cells
also expressed CD2, CD3, CD5, and CD7. The
staging for her T-cell lymphoma was stage IVb.
The patient was initially treated with pazopanib
and experienced no improvement after 2 months of
200-mg daily therapy. Cyclosporine and cyclophos-
phamide were also considered as treatment options.
Because of persistent and significant pruritus, the
patient was started on systemic psoralen and
ultraviolet A therapy which provided symptomatic
improvement. Further systemic chemotherapy was
offered and declined by the patient.DISCUSSION
Lymphomas coexisting in the same patient
are classified by the Working Formulation ofnon-Hodgkins lymphomas into three categories.1
Discordant lymphomas are two histologically
distinct lymphomas at two different anatomic sites.
Composite lymphomas have two types of lymphoma
within the same anatomic lesion. Lymphomas may
also occur sequentially in which the second is known
as secondary lymphoma.
Several cases in the literature report MF as a risk
factor for secondary non-Hodgkins lymphomas,
and, rarely, Hodgkins lymphomas.2-8 Explanations
have been proposed for this association; the use of
immunosuppressants in the treatment of the primary
lesion, a genetic predisposition to malignancy,
and the monoclonal proliferation of T cells in
MF modulating the B-cell system, have all been
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Epstein-Barr virus has also been implicated in driving
a B-cell lymphoproliferative process in patients with
MF; the Epstein Barr virus studies in our patient were
negative.10
Although it is a well known, yet rare, occurrence
for MF to present with a secondary B-cell
malignancy, it is exceedingly rare to find the two
presenting simultaneously. Our patient presented
with discordant cutaneous lymphomas in two
anatomically distinct locations occurring roughly
within the same timeframe. There are no docu-
mented cases of simultaneous presentation of
discordant cutaneous lymphomas, to our know-
ledge, as most occur as a secondary lymphoma.
Our case further supports the need to perform
multiple biopsies when patients present with
morphologically different cutaneous findings.
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